Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation
Recruiting · NCT06291922 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Pennsylvania
View the official record on ClinicalTrials.gov →Interventions studied
Exercise InterventionUsual Care
What this trial is about
The goal of this clinical trial is to evaluate the effects of a home-based exercise program using mobile technology on physical activity and capacity, frailty and muscle mass, and quality of life in patients with a newly implanted HeartMate 3 left ventricular assist device (HM3 LVAD). Researchers will compare the effects of an exercise intervention vs. usual care on physical activity and capacity, frailty and muscle mass, and quality of life.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- ≥ 18 years of age
- Newly implanted with a HeartMate 3™ LVAD for the first time
- Able to ambulate independently (with or without the use of an assistive device)
- Owns a smartphone with Internet connection
- Patient will be discharged home with LVAD or patient will be living at home with LVAD within 45 days of index discharge
Exclusion criteria
- \. Major comorbidities or limitations that may interfere with exercise training (including significant orthopedic/neurologic limitations, decompensated heart failure, uncontrolled arrhythmias, unstable angina)
Where it is running
4 locations listed across 4 US states.
- Henry Ford Health - Detroit, Michigan, United States
- Cleveland Clinic Foundation - Cleveland, Ohio, United States
- University of Pennsylvania - Philadelphia, Pennsylvania, United States
- University of Utah Health - Salt Lake City, Utah, United States